The design and validation of a new device to detect prostate cancer, in a more effective, precise and less invasive manner than the rectal examination, has been financed by the regional business competitiveness institute (Ivace).
A clinical trial has corroborated the effectiveness of this new tool, called Prostacto, which is portable, easy to use and low cost, explained regional councillor for innovation Nuria Montes.
Full report in Friday’s Costa Blanca News
